These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3106921)

  • 1. Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system.
    Dougan G; Hormaeche CE; Maskell DJ
    Parasite Immunol; 1987 Mar; 9(2):151-60. PubMed ID: 3106921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of strain viability and antigen dose on the use of attenuated mutants of Salmonella as vaccine carriers.
    Cárdenas L; Dasgupta U; Clements JD
    Vaccine; 1994 Jul; 12(9):833-40. PubMed ID: 7975861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Salmonella vectors in vaccine development.
    Curtiss R; Kelly SM; Tinge SA; Tacket CO; Levine MM; Srinivasan J; Koopman M
    Dev Biol Stand; 1994; 82():23-33. PubMed ID: 7958478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An attenuated aroA Salmonella typhimurium vaccine elicits humoral and cellular immunity to cloned beta-galactosidase in mice.
    Brown A; Hormaeche CE; Demarco de Hormaeche R; Winther M; Dougan G; Maskell DJ; Stocker BA
    J Infect Dis; 1987 Jan; 155(1):86-92. PubMed ID: 3098864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.
    Chen H; Schifferli DM
    Infect Immun; 2000 Jun; 68(6):3129-39. PubMed ID: 10816454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a pilin subunit BfpA of the bundle-forming pilus of enteropathogenic Escherichia coli in an aroA live salmonella vaccine strain.
    Schriefer A; Maltez JR; Silva N; Stoeckle MY; Barral-Netto M; Riley LW
    Vaccine; 1999 Feb; 17(7-8):770-8. PubMed ID: 10067682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae.
    Ryan ET; Crean TI; John M; Butterton JR; Clements JD; Calderwood SB
    Infect Immun; 1999 Apr; 67(4):1694-701. PubMed ID: 10085006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of oral vaccines based on live attenuated Salmonella strains.
    Chatfield S; Roberts M; Londono P; Cropley I; Douce G; Dougan G
    FEMS Immunol Med Microbiol; 1993 Jun; 7(1):1-7. PubMed ID: 8364518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli.
    Koprowski H; Levine MM; Anderson RJ; Losonsky G; Pizza M; Barry EM
    Infect Immun; 2000 Sep; 68(9):4884-92. PubMed ID: 10948101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live attenuated Salmonella vaccines and their potential as oral combined vaccines carrying heterologous antigens.
    Hormaeche CE
    J Immunol Methods; 1991 Aug; 142(1):113-20. PubMed ID: 1919015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas.
    Clements JD; El-Morshidy S
    Infect Immun; 1984 Nov; 46(2):564-9. PubMed ID: 6389350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems.
    Maskell DJ; Sweeney KJ; O'Callaghan D; Hormaeche CE; Liew FY; Dougan G
    Microb Pathog; 1987 Mar; 2(3):211-21. PubMed ID: 3333799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of live attenuated Salmonella for oral vaccination.
    Chatfield S; Roberts M; Li J; Starns A; Dougan G
    Dev Biol Stand; 1994; 82():35-42. PubMed ID: 7958481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated
    Liu Q; Li P; Luo H; Curtiss R; Kong Q
    Virulence; 2019 Dec; 10(1):82-96. PubMed ID: 31874075
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of vector priming on the immunogenicity of recombinant Salmonella vaccines.
    Vindurampulle CJ; Attridge SR
    Infect Immun; 2003 Jan; 71(1):287-97. PubMed ID: 12496178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live Salmonella as vaccines and carriers of foreign antigenic determinants.
    Chatfield SN; Strugnell RA; Dougan G
    Vaccine; 1989 Dec; 7(6):495-8. PubMed ID: 2481908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine antibody response to oral infection with live aroA recombinant Salmonella dublin vaccine strains expressing filamentous hemagglutinin antigen from Bordetella pertussis.
    Molina NC; Parker CD
    Infect Immun; 1990 Aug; 58(8):2523-8. PubMed ID: 2370105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specific systemic and reproductive tract antibodies in foxes immunized with Salmonella typhimurium expressing bacterial and sperm proteins.
    de Jersey J; Bird PH; Verma NK; Bradley MP
    Reprod Fertil Dev; 1999; 11(4-5):219-28. PubMed ID: 10898286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat-labile enterotoxin.
    Bost KL; Clements JD
    Infect Immun; 1995 Mar; 63(3):1076-83. PubMed ID: 7868230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous oral immunization of mice with live attenuated Escherichia coli expressing LT192-STa 13 and LT 192-STb fusion immunogen, respectively, for polyvalent vaccine candidate.
    Liu W; Li J; Bao J; Li X; Guan W; Yuan C; Tang J; Zhao Z; Shi D
    Appl Microbiol Biotechnol; 2015 May; 99(9):3981-92. PubMed ID: 25549617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.